Philip S LaRussa
Affiliation: Columbia University
- Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment NetworkPhilip S LaRussa
Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, New York, NY, USA
Pediatrics 127:S65-73. 2011..The CISA Network serves as a unique resource for vaccine-safety monitoring efforts conducted at the CDC...
- Pandemic novel 2009 H1N1 influenza: what have we learned?Philip Larussa
Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
Semin Respir Crit Care Med 32:393-9. 2011..Continued efforts to develop universal vaccines and improve access to effective vaccines are critical...
- A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicellaAnne A Gershon
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Pediatr Infect Dis J 28:653-5. 2009..There were no serious adverse events. Two years after vaccination 82% of subjects remained VZV-antibody positive and 60% had VZV-specific cell-mediated immunity. No child developed herpes zoster...
- Primary vaccine failure after 1 dose of varicella vaccine in healthy childrenDavid E Michalik
Division of Pediatric Infectious Diseases, Columbia University Medical Center, New York, New York 10032, USA
J Infect Dis 197:944-9. 2008..A second dose of varicella vaccine is expected to increase seroconversion rates and vaccine effectiveness...
- Effectiveness of 2 doses of varicella vaccine in childrenEugene D Shapiro
Department of Pediatrics, Yale University School of Medicine and Graduate School of Arts and Sciences, New Haven, Connecticut 06520 8064, USA
J Infect Dis 203:312-5. 2011..Because of ongoing outbreaks of varicella, a second dose of varicella vaccine was added to the routine immunization schedule for children in June 2006 by the Centers for Disease Control and Prevention...
- Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety dataPhilip L Graham
Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, New York Presbyterian Hospital, New York, NY, USA
Vaccine 25:5763-70. 2007
- Risk of herpes zoster in adults immunized with varicella vaccineSophie Hambleton
Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA
J Infect Dis 197:S196-9. 2008..00 case/1000 person-years. Overall, the incidence of HZ in this cohort, therefore, is similar to published data for the US population in the prevaccine era...
- Effectiveness over time of varicella vaccineMarietta Vazquez
Department of Pediatrics, Yale University School of Medicine, New Haven, Conn 06520 8064, USA
JAMA 291:851-5. 2004..Reports of outbreaks of varicella in highly immunized groups have increased concern about the effectiveness of varicella vaccine...
- Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunctionPatrick Jean-Philippe
Department of Pediatrics, New York University School of Medicine, New York, New York, USA
Pediatrics 120:e1345-9. 2007..We report here an 18-month-old girl with cell-mediated immunodeficiency who developed a severe vaccine-associated rash and clinical evidence of vaccine-associated pneumonia 1 month after inadvertent receipt of varicella vaccine...